MedPath

Allopurinol

ALLOPURINOL TABLETS USP  100 mg and 300 mg  Rx Only

Approved
Approval ID

11f1fc6e-b274-4132-9edd-522a819a479b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 16, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Allopurinol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-6716
Application NumberANDA204467
Product Classification
M
Marketing Category
C73584
G
Generic Name
Allopurinol
Product Specifications
Route of AdministrationORAL
Effective DateDecember 14, 2021
FDA Product Classification

INGREDIENTS (5)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
ALLOPURINOLActive
Quantity: 100 mg in 1 1
Code: 63CZ7GJN5I
Classification: ACTIB
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Allopurinol - FDA Drug Approval Details